患有外周动脉疾病的患者的心血管预后和治疗方法
Antonio Curcio1, Alessandra Panarello1, Carmen Spaccarotella2
1Division of Cardiology, Department of Medical and Surgical Sciences, Magna Graecia University, 88100 Catanzaro, Italy.
Biomedicines
|December 23, 2023
概括
周围动脉疾病 (PAD) 影响全球超过2亿人,意味着高心血管风险. 早期识别和积极管理PAD对于改善患者的治疗结果和预防心脏病发作和中风至关重要.
科学领域:
- 心血管医学 心血管医学
- 血管外科 血管外科
- 动脉样硬化研究 动脉样硬化研究
背景情况:
- 周围动脉疾病 (PAD) 影响全球超过2亿人,其特点是下肢动脉的动脉样硬化.
- PAD是系统性动脉样硬化的一个重要指标,增加了心肌梗塞和中风的风险.
- 鉴定PAD,特别是在冠状动脉疾病 (CAD) 患者中,对于准确的心血管风险评估和向治疗至关重要.
研究的目的:
- 提供PAD的全面审查,涵盖其病理生理学,诊断和预后.
- 详细介绍PAD目前的管理策略,包括风险因素修改,抗血栓治疗和再血管化.
- 探索晚期PAD的新兴治疗方案,例如"沙漠脚"疾病的基因疗法.
主要方法:
- 文献综述专注于PAD的病理生理学,诊断,预后和管理.
- 与PAD相关的心血管事件,冠状动脉疾病和心力衰竭的分析.
- 讨论PAD的当代和新型治疗方式.
主要成果:
- PAD是心血管事件的关键预测因素,经常超过传统的风险因素.
- 对PAD和CAD的综合管理对于优化患者的治疗结果至关重要.
- 新的治疗途径,包括基因疗法,对耐火性PAD病例显示出希望.
结论:
- 在医疗专业中,需要采取积极的方法来识别和治疗PAD.
- 预防策略对于改善CAD和PAD同时存在的患者的预后至关重要.
- 为了管理复杂的PAD病例,需要对先进疗法的持续研究.
更多相关视频
相关概念视频
01:16Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
221
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
221
01:20Exercise and Cardiovascular Response
820
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
820
01:26Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
171
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
171
01:18Cardiovascular Drugs: Classification based on Therapeutic Indications
2.9K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.9K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
436
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
436
01:17Ischemic Heart Disease: Overview
1.3K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.3K